Alignment Healthcare
ALHC
8.55
+0.18
+2.15%
Alignment Healthcare
US · ALHC
#2907 by market cap
Listed 2021
8.55
+0.18
+2.15%
Live - 5344 symbols - heartbeat 553s ago
· 2026-10-08 07:26
Pre-market
8.60
+0.58%
After-hours
8.57
+0.23%
Overnight
8.57
+0.23%
- Market cap
- 1.77B
- P/E (TTM)i
- 45.97
- P/Bi
- 6.69
- EPSi
- 0.00
- Div yieldi
- 0.00%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on ALHC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.07, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +46.06% YoY
Margins
- Gross margin
- 12.37%
- Operating margin
- 0.37%
- Net margin
- -0.02%
Key ratios & quality
- Altman Z-Scorei
- 4.07
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 756.96M | 959.22M | 1.17B | 1.43B | 1.82B | 2.70B | 3.95B |
| Gross profit | 95.57M | 166.23M | 128.73M | 184.28M | 201.03M | 296.69M | 488.56M |
| Selling & admin expenses | 110.13M | 156.40M | 290.99M | 295.65M | 307.43M | 371.37M | 443.41M |
| Research & development | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -29.48M | -5.26M | -178.07M | -128.64M | -127.82M | -101.56M | 14.75M |
| Pretax profit | -44.73M | -22.93M | -195.29M | -149.30M | -148.20M | -128.05M | -958.00K |
| Tax | 0 | 0 | 0 | 339.00K | -22.00K | 21.00K | 20.00K |
| Net profit | -44.73M | -22.93M | -195.29M | -149.64M | -148.17M | -128.07M | -978.00K |
| Basic EPS | 0 | 0 | -1 | -1 | -1 | -1 | 0 |
| Diluted EPS | -0.29 | -0.12 | -1.14 | -0.83 | -0.79 | -0.67 | 0.00 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 926.93M | 1.02B | 993.70M | 1.01B | 1.24B | 1.34B |
| Gross profit | 106.03M | 133.55M | 125.67M | 123.31M | 144.48M | 180.96M |
| Selling & admin expenses | 103.83M | 103.80M | 110.02M | 125.76M | 121.14M | 131.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -5.39M | 22.75M | 7.68M | -10.28M | 15.50M | 42.10M |
| Pretax profit | -9.33M | 18.88M | 3.73M | -14.23M | 11.44M | 37.83M |
| Tax | 21.00K | 3.22M | 2.00K | -3.23M | 25.00K | 1.27M |
| Net profit | -9.35M | 15.65M | 3.73M | -11.01M | 11.42M | 36.56M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.05 | 0.07 | 0.02 | -0.05 | 0.05 | 0.17 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 127.35M | 264.68M | 552.86M | 544.55M | 483.54M | 661.64M | 951.58M |
| Cash & ST investments | 86.48M | 207.31M | 466.60M | 409.55M | 318.82M | 470.65M | 604.23M |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 193.44M | 338.50M | 630.90M | 633.86M | 591.88M | 782.06M | 1.07B |
| Total current liabilities | 130.26M | 153.45M | 167.25M | 229.96M | 263.02M | 351.85M | 556.87M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | 137.96M | 144.17M | 150.62M | 160.90M | 161.81M | 321.43M | 323.18M |
| Total liabilities | 272,154,000.00 | 307,891,000.00 | 324,840,000.00 | 394,561,000.00 | 433,809,000.00 | 681,108,000.00 | 886,509,000.00 |
| Total equity | -78.71M | 30.61M | 306.06M | 239.30M | 158.07M | 100.96M | 179.28M |
| Retained earnings | -78.71M | -379.57M | -582.69M | -732.24M | -880.26M | -1.01B | -1.01B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 774.49M | 880.12M | 985.32M | 951.58M | 1.15B | 1.16B |
| Cash & ST investments | 479.54M | 503.78M | 644.08M | 604.23M | 726.29M | 701.71M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 895.62M | 1.00B | 1.10B | 1.07B | 1.26B | 1.28B |
| Total current liabilities | 457.12M | 529.53M | 611.09M | 556.87M | 724.76M | 683.41M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 321.86M | 322.30M | 322.74M | 323.18M | 323.62M | 324.06M |
| Total liabilities | 786,622,000.00 | 859,183,000.00 | 940,743,000.00 | 886,509,000.00 | 1,054,723,000.00 | 1,013,907,000.00 |
| Total equity | 109.00M | 140.97M | 161.87M | 179.28M | 206.89M | 265.13M |
| Retained earnings | -1.02B | -1.00B | -998.01M | -1.01B | -997.60M | -961.04M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 9.21M | 7.56M | -78.78M | -45.43M | -59.19M | 34.77M | 139.93M |
| Depreciation & amortization | 16.58M | 15.46M | 16.03M | 17.49M | 21.67M | 27.06M | 30.48M |
| Free cash flow | -1.04M | -8.15M | -97.14M | -69.20M | -95.18M | -6.65M | 113.15M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -1.48M | 133.50M | 389.13M | -- | -- | -- | -- |
| Ending cash balance | 86.48M | 207.81M | 468.35M | 411.30M | 204.95M | 434.94M | 577.94M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 16.62M | 29.13M | 144.56M | -50.38M | 128.68M | -17.31M |
| Depreciation & amortization | 7.63M | 7.04M | 7.99M | 7.83M | 7.86M | 7.86M |
| Free cash flow | 8.36M | 21.13M | 139.06M | -55.40M | 121.32M | -27.46M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 448.28M | 472.36M | 620.18M | 577.94M | 707.71M | 695.59M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -116.02 | -55.00 | -74.93 | -99.72 | -0.52 |
| ROA %i | -23.12 | -8.62 | -40.29 | -23.66 | -24.15 | -18.64 | -0.08 |
| ROIC %i | -- | -- | -54.83 | -31.21 | -34.72 | -28.92 | 2.51 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -69.23 |
| EBIT margin %i | -3.94 | -0.63 | -15.23 | -9.14 | -6.96 | -3.87 | 0.38 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | 2.87 |
| Current ratioi | 0.98 | 1.72 | 3.31 | 2.37 | 1.84 | 1.88 | 1.71 |
| Quick ratioi | 0.94 | 1.61 | 3.14 | 2.18 | 1.67 | 1.78 | 1.54 |
| Debt / assetsi | 71.32 | 45.62 | 24.98 | 25.97 | 28.86 | 42.10 | 30.93 |
| LT debt / equityi | -- | 504.52 | 51.49 | 69.12 | 108.82 | 329.75 | 183.87 |
| Interest coveragei | -2.00 | -0.35 | -10.20 | -7.16 | -5.98 | -4.44 | 0.94 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 23.74 | 23.88 | 32.29 | 40.16 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -75.82 | -38.50 | -15.06 | -0.52 | 12.57 | 20.04 |
| ROA %i | -11.86 | -5.94 | -2.32 | -0.08 | 1.84 | 3.57 |
| ROIC %i | -19.81 | -8.57 | -1.72 | 2.51 | 7.33 | 9.46 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -2.29 | -0.83 | -0.01 | 0.38 | 0.84 | 1.20 |
| FCF / sales %i | 0.64 | 0.85 | 4.14 | 2.87 | 5.31 | 3.88 |
| Current ratioi | 1.69 | 1.66 | 1.61 | 1.71 | 1.58 | 1.70 |
| Quick ratioi | 1.52 | 1.49 | 1.41 | 1.54 | 1.39 | 1.46 |
| Debt / assetsi | 36.79 | 32.96 | 29.90 | 30.93 | 26.15 | 25.84 |
| LT debt / equityi | 304.73 | 233.85 | 203.65 | 183.87 | 159.49 | 124.66 |
| Interest coveragei | -3.11 | -1.36 | -0.03 | 0.94 | 2.25 | 3.39 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Provide healthcare services to our seniors100.00%
Quote time 2026-10-08 07:26:39 · For reference only, not investment advice and not tailored to your situation.